Recombinant Rat G protein-activated inward rectifier potassium channel 1 (Kcnj3)

Shipped with Ice Packs
In Stock

Description

Gene and Protein Information

Recombinant rat Kcnj3 encodes a 501-amino acid protein with a molecular weight of approximately 56 kDa . Key genomic features include:

FeatureDetails
SpeciesRattus norvegicus
Gene SymbolKcnj3
Chromosomal Location3q21
Protein Residues501
Molecular Weight~56 kDa
Transmembrane Domains2 (residues 81–105, 158–179)
UniProt IDP63251
Homology98% amino acid identity with mouse Kir3.1

The gene spans over 45 kb with three exons, where exon 1 encodes transmembrane domains and part of the C-terminus . Promoter analysis reveals GC-rich regions and transcription factor-binding elements critical for basal expression .

Recombinant Expression Systems

Rat Kcnj3 has been successfully expressed in multiple heterologous systems:

CHO (Chinese Hamster Ovary) Cells

  • Demonstrated functional coupling with G proteins and receptor-activated currents .

  • Temperature-dependent expression:

    • 25°C: 48 cells tested showed stable channel activity

    • 35°C: 23 cells exhibited enhanced current kinetics

Xenopus Oocytes

  • Coexpression with hGIRK1 (human homolog) increased basal currents by 300% compared to single-subunit expression .

  • Agonist-induced currents were amplified 5-fold when coexpressed with G protein-coupled receptors (GPCRs) .

Mammalian Cell Lines

  • Produced non-glycosylated 45 kDa protein in CHO cells .

  • Antibody co-precipitation confirmed heteromeric assembly with other GIRK subunits .

Functional Characteristics

PropertyDetails
Activation MechanismRequires PIP₂ and Gβγ subunits released from Gi/o proteins .
RectificationBlocked by intracellular Mg²⁺ and polyamines .
Voltage DependenceRegulated by extracellular K⁺ concentration .
Single-Channel Conductance~35 pS (in symmetrical K⁺ conditions) .

Pain Modulation

  • Post-axotomy downregulation in rat dorsal root ganglion (DRG) neurons correlates with hyperexcitability and chronic pain .

  • Key Data:

    • GIRK1 mRNA reduced by 60% in DRG neurons 7 days post-injury .

    • Spinal cord GIRK1 protein levels decreased by 45% after peripheral nerve damage .

Cardiac Regulation

  • Atrial-specific expression stabilizes resting membrane potential (-85 mV) .

  • Knockout models show prolonged action potential duration and arrhythmia susceptibility .

Applications in Research

  • Drug Screening: Used to study alcohol modulation and novel GIRK activators (e.g., ML297) .

  • Disease Models:

    • Cardiac arrhythmia studies .

    • Neuropathic pain mechanisms .

  • Structural Biology: Cryo-EM studies of rat Kcnj3/Gβγ complexes revealed pre-open channel conformations .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order remarks; we will accommodate your request if possible.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
Kcnj3; Girk1; Kga; G protein-activated inward rectifier potassium channel 1; GIRK-1; Inward rectifier K(+ channel Kir3.1; KGA; KGB1; Potassium channel, inwardly rectifying subfamily J member 3
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-501
Protein Length
Full length protein
Species
Rattus norvegicus (Rat)
Target Names
Target Protein Sequence
MSALRRKFGDDYQVVTTSSSGSGLQPQGPGQGPQQQLVPKKKRQRFVDKNGRCNVQHGNL GSETSRYLSDLFTTLVDLKWRWNLFIFILTYTVAWLFMASMWWVIAYTRGDLNKAHVGNY TPCVANVYNFPSAFLFFIETEATIGYGYRYITDKCPEGIILFLFQSILGSIVDAFLIGCM FIKMSQPKKRAETLMFSEHAVISMRDGKLTLMFRVGNLRNSHMVSAQIRCKLLKSRQTPE GEFLPLDQLELDVGFSTGADQLFLVSPLTICHVIDAKSPFYDLSQRSMQTEQFEVVVILE GIVETTGMTCQARTSYTEDEVLWGHRFFPVISLEEGFFKVDYSQFHATFEVPTPPYSVKE QEEMLLMSSPLIAPAITNSKERHNSVECLDGLDDISTKLPSKLQKITGREDFPKKLLRMS STTSEKAYSLGDLPMKLQRISSVPGNSEEKLVSKTTKMLSDPMSQSVADLPPKLQKMAGG PTRMEGNLPAKLRKMNSDRFT
Uniprot No.

Target Background

Function

This G protein-regulated potassium channel belongs to the inward rectifier potassium channel family. These channels exhibit a preference for potassium influx over efflux. Their voltage dependence is modulated by extracellular potassium concentration; increasing external potassium shifts the channel activation voltage range to more positive potentials. Inward rectification is primarily attributed to internal magnesium blockage. This receptor plays a critical role in cardiac rhythm regulation.

Gene References Into Functions
  1. Transient mGluR activation reduced GIRK currents evoked by GABAB and D2 receptors, although less effectively for D2. PMID: 28009293
  2. This study suggests Kir3.1 involvement in sinus bradycardia pathogenesis, as siRNA-mediated inhibition reversed the condition. PMID: 28205094
  3. Findings highlight the prefrontal cortex's unique vulnerability to early developmental nutritional deficits, leading to long-term effects on KCNJ3 expression and basal metabolic activity. PMID: 25446346
  4. Basal Kir3 current in its native environment is independent of G-protein signaling or agonist-independent free G-beta-gamma. PMID: 24576551
  5. Atrium-specific Kir3.x channels regulate the inducibility, dynamics, and termination of fibrillation through restitution-driven alternans. PMID: 24065610
  6. NgR1 siRNA knockdown selectively increased GABAB R1 and GABAB R2 protein levels and GIRK1 expression. PMID: 23829864
  7. This study investigated GIRK regulation by Galpha(i/o) using wild-type Galpha(i3) (Galpha(i3)WT) and mutant Galpha(i3). PMID: 21795707
  8. Neuronal GIRK channel surface expression is regulated by the psychostimulant-sensitive sorting nexin 27 (SNX27) protein via a class I PDZ-binding interaction. PMID: 21422294
  9. Mutating a GIRK1 N-terminal hydrophobic residue predicted to interact with the C-terminal domain reduced channel function and termini association. Its hydrophobicity is crucial for termini interaction and channel gating. PMID: 15716420
  10. G protein-receptor kinase 2- and beta-arrestin 2-dependent internalization of the M(2) receptor into clathrin-coated vesicles may significantly contribute to I(K,ACh) desensitization. PMID: 17012364
  11. Ibir, a homotetrameric Kir3.4 channel current, exhibits unique regulatory and pharmacological properties. Ibir shares similarities with a basal current observed in atrial myocytes from an animal model of atrial fibrillation (AF) and AF patients. PMID: 17884923
  12. This study characterized the structure and function of a novel GIRK1 splice variant from rat brain; the GIRK1d variant preferentially binds GIRK2 or GIRK4 over GIRK1, substantially reducing conductances mediated by GIRK1/2 or GIRK1/4 heteromultimeric channels. PMID: 18097938
  13. The results demonstrate the differential developmental and hormonal regulation of GIRK(2) in the rat CNS. PMID: 18178009
  14. This study describes the localization of GIRK1, GIRK2, and GIRK3 subunits and the 5-HT(1A) receptor in rat brain, and their co-expression with markers of glutamatergic, GABAergic, cholinergic, and serotonergic neurons. PMID: 18698588
Database Links

KEGG: rno:50599

STRING: 10116.ENSRNOP00000007335

UniGene: Rn.9809

Protein Families
Inward rectifier-type potassium channel (TC 1.A.2.1) family, KCNJ3 subfamily
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is the basic structure of G protein-activated inward rectifier potassium channel 1 (Kcnj3/GIRK1) and how does it differ from other potassium channels?

GIRK1 (Kcnj3) belongs to the inwardly rectifying potassium channel family and functions as a component of tetrameric ion channels. Each GIRK subunit possesses two transmembrane domains (TM1 and TM2) that flank a hydrophobic pore domain, with intracellular N-terminal and C-terminal domains . Unlike voltage-gated potassium channels with six transmembrane segments, GIRK channels have this simpler two-transmembrane topology.

The distinctive feature of GIRK1 is its inability to form functional homomeric channels, instead requiring assembly with other GIRK subunits (typically GIRK2, GIRK3, or GIRK4) to create functional heterotetrameric channels. This heteromeric assembly is essential for proper channel function in native tissues. The C-terminal domain of GIRK1 is particularly important, with research showing that the distal C-terminus plays a crucial role in channel activation .

How do the electrophysiological properties of GIRK1-containing channels differ from other inward rectifiers?

GIRK1-containing channels demonstrate strong inward rectification, meaning they preferentially allow potassium to flow into the cell rather than out of it . This rectification mechanism is primarily due to voltage-dependent block by intracellular magnesium, which obstructs outward current flow at depolarized potentials .

The voltage-dependence of GIRK channels is uniquely regulated by extracellular potassium concentration; as external potassium concentration increases, the voltage range for channel opening shifts toward more positive potentials . This property distinguishes them from some other inward rectifiers.

GIRK channels exhibit characteristically low open channel probability, which presents challenges for structural studies attempting to capture them in the open state . This property also affects their functional analysis in electrophysiological experiments and necessitates specialized approaches to study their gating mechanisms.

What are the key functional domains of GIRK1 and their roles in channel modulation?

GIRK1 contains several critical functional domains that regulate channel activity:

DomainLocationFunction in Channel Regulation
N-terminusIntracellularPrimary Gβγ binding site essential for G protein-mediated activation
Transmembrane domains (TM1, TM2)Membrane-spanningForm the ion conduction pathway and contribute to channel gating
Pore domainBetween TM1 and TM2Determines K+ selectivity and contributes to inward rectification
C-terminus (proximal)IntracellularContains secondary Gβγ binding site unique to GIRK1
C-terminus (distal)IntracellularCritical for channel function; contains Q404 residue that influences receptor-activated channel activity

The C-terminal domain of GIRK1 deserves special attention as it contains unique features not found in other GIRK subunits. Research has revealed that GIRK1 possesses an additional Gβγ-interacting segment in the first half of its C-terminus, and specific leucine residues in this region can alter channel properties without affecting Gβγ binding . This suggests a role in modulating the conformational changes induced by G protein binding.

What techniques are most effective for detecting native versus recombinant GIRK1 expression?

For detecting GIRK1 expression in various experimental settings, several techniques have proven effective:

Western Blotting:

  • For native GIRK1: Use polyclonal antibodies at dilutions of 1:500-1:5000

  • For recombinant GIRK1: Tag-specific antibodies may provide better specificity when using epitope-tagged constructs

Immunofluorescence:

  • Optimal dilutions for polyclonal antibodies range from 1:200-1:1000

  • Confocal microscopy provides superior resolution for subcellular localization studies

Electrophysiology:

  • Patch-clamp techniques can confirm functional expression

  • While GIRK channels exhibit low open probability , their distinctive inward rectification properties and G protein sensitivity serve as functional signatures

When detecting native GIRK1 in neuronal tissues, it's important to note that GIRK1-3 are widely expressed in the rodent brain, including the cerebral cortex, amygdala, hippocampus, thalamus, ventral tegmental area, locus coeruleus, and cerebellum . This broad distribution requires careful consideration of regional specificity in experimental design.

What are the optimal conditions for producing functional recombinant rat GIRK1 protein?

Producing functional recombinant rat GIRK1 requires careful consideration of several factors:

Expression System Selection:

  • Mammalian expression systems (HEK293, CHO cells) better reflect native processing compared to bacterial systems

  • Co-expression with other GIRK subunits (typically GIRK2 or GIRK4) is essential as GIRK1 alone does not form functional homomeric channels

Optimal Transfection Protocols:

  • For transient expression: Lipid-based transfection with 48-72 hour expression period

  • For stable expression: Selection with appropriate antibiotics followed by single-cell cloning

Purification Considerations:

  • Addition of an affinity tag (His, FLAG) facilitates purification

  • Mild detergents like DDM or digitonin better preserve protein structure compared to harsher detergents

  • Inclusion of lipids during purification helps maintain channel structure and function

Functional Verification:

  • Patch-clamp electrophysiology remains the gold standard for confirming channel function

  • Fluorescence-based assays using thallium flux can provide higher throughput screening of channel activity

It's crucial to verify that the recombinant protein maintains its G protein sensitivity, as this is the defining characteristic of GIRK channels. This can be achieved through co-expression with G protein-coupled receptors or direct application of purified Gβγ subunits.

How can researchers distinguish between different GIRK1 splice variants in experimental settings?

Distinguishing between GIRK1 splice variants (such as GIRK1a, GIRK1c, and GIRK1d) requires specialized approaches:

RT-PCR and qPCR:

  • Design primers that span variant-specific exon junctions

  • Use variant-specific probes for increased specificity in qPCR applications

Western Blotting:

  • Size discrimination can be effective as variants differ in molecular weight (GIRK1a being 56 kDa)

  • Variant-specific antibodies targeting unique regions are optimal but challenging to develop

Functional Discrimination:

  • GIRK1d acts as a dominant negative of functional GIRK complexes, unlike GIRK1a and GIRK1c which enhance channel activity

  • Electrophysiological characterization can differentiate variants based on these functional differences

Domain-Specific Analysis:

  • The segment comprising amino acids 235-402 (present in GIRK1a and GIRK1c but not GIRK1d) is particularly important for differentiating variants

  • Immunoprecipitation with domain-specific antibodies can help identify specific variants

Research has shown that these splice variants can have dramatically different effects on cellular physiology. For example, while GIRK1a and GIRK1c overexpression promotes malignant parameters in breast cancer cells, GIRK1d overexpression has the opposite effect . This functional divergence provides a means to confirm the identity of expressed variants.

What methodologies best capture the relationship between GIRK1 channels and addiction pathways?

Investigating GIRK1's role in addiction requires multi-level approaches:

Genetic Manipulation Models:

  • GIRK1 knockout mice show hyperactivity and altered locomotor responses to cocaine

  • Channel-specific mutations in key regulatory residues can provide more nuanced insights than complete knockouts

Behavioral Paradigms:

  • Self-administration protocols reveal that GIRK2 and GIRK3 knockout mice exhibit decreased cocaine self-administration

  • Conditioned place preference assays demonstrate that GIRK2 knockout mice lack alcohol-induced conditioned taste aversion or place preference

Circuit-Specific Approaches:

  • Localized viral-mediated gene manipulation in reward circuits

  • Optogenetic or chemogenetic control of GIRK-expressing neurons allows temporal precision

Electrophysiological Recordings:

  • Ex vivo brain slice recordings from regions like the VTA and nucleus accumbens

  • In vivo recordings during drug exposure or addictive behaviors

Molecular Endpoints:

  • Analysis of GIRK phosphorylation states following drug exposure

  • Assessment of channel trafficking and surface expression changes

Research has revealed that GIRK3 knockout mice show reduced alcohol withdrawal symptoms and increased alcohol binge-like drinking behavior . Human genomic studies have identified SNPs in noncoding regions of KCNJ6 (GIRK2) that link to frontal inhibitory control in individuals with alcohol use disorders and can reduce GIRK2 expression while increasing cellular excitability .

How can researchers effectively study the direct interaction between G proteins and GIRK1 channels?

Studying G protein-GIRK1 interactions requires sophisticated biochemical and biophysical approaches:

Co-Immunoprecipitation:

  • Pull-down assays using antibodies against GIRK1 or G protein subunits

  • Can be performed with crosslinking to capture transient interactions

FRET/BRET Approaches:

  • Fluorescent or bioluminescent tagging of GIRK1 and G protein subunits

  • Allows real-time monitoring of interactions in living cells

Structural Biology Techniques:

  • Cryo-EM has significantly advanced understanding of GIRK-Gβγ interactions

  • Co-crystallization of channel fragments with G protein components

Functional Electrophysiology:

  • Patch-clamp recording with direct application of purified G protein subunits

  • Inside-out patch configuration allows controlled exposure of the cytoplasmic face

Mutagenesis Strategies:

  • Point mutations in the N-terminal and C-terminal Gβγ binding sites

  • Creation of chimeric channels to isolate interaction domains

Research has revealed that while both GIRK1 and GIRK2 subunits bind Gβγ at the N-terminus, GIRK1 possesses an additional Gβγ-interacting segment in the first half of its C-terminus . This discovery highlights the importance of examining multiple potential interaction sites when studying G protein coupling.

What experimental approaches can quantify the influence of the GIRK1 C-terminal domain on channel gating?

The C-terminal domain of GIRK1 plays a crucial role in channel function, requiring specialized experimental approaches:

Truncation and Deletion Analysis:

  • Systematic truncation series of the C-terminus

  • Deletion of specific motifs to identify functional elements

Site-Directed Mutagenesis:

  • Mutation of key residues such as Q404, which influences receptor-activated channel activity

  • Alanine-scanning mutagenesis of leucine residues that affect channel properties

Chimeric Channel Construction:

  • Exchanging C-terminal regions between different GIRK subunits

  • Creating chimeras with non-GIRK inward rectifiers

Single-Channel Recording:

  • Analysis of open probability and kinetics in response to C-terminal modifications

  • Determination of subconductance states that may reflect partial activation

Intramolecular FRET:

  • Placement of fluorophores to monitor conformational changes

  • Can detect relative movement of the C-terminus during gating

Research has shown that mutations in specific C-terminal leucine residues of GIRK1 altered channel properties without affecting Gβγ binding, indicating their role in modulating conformational changes during channel gating . This suggests that the C-terminus serves as more than just a binding site, acting as a transducer of G protein binding to channel opening.

How should researchers approach contradictory findings regarding GIRK1 function in different model systems?

Addressing contradictory findings requires systematic analysis and experimental design:

Source of Variation Analysis:

  • Evaluate differences in expression systems (heterologous vs. native tissue)

  • Consider species differences in GIRK1 sequence and regulation

  • Assess the influence of different GIRK heterotetrameric compositions

Standardization Approaches:

  • Establish consistent recording conditions for electrophysiological studies

  • Use identical purification protocols when comparing recombinant proteins

  • Apply the same analytical methods across datasets

Multi-level Validation:

Contextual Factors:

  • Consider the influence of auxiliary proteins and lipid environment

  • Evaluate post-translational modifications across different systems

  • Assess the impact of cellular signaling states

What integrated approaches best elucidate the role of GIRK1 in pathophysiological conditions?

Understanding GIRK1's role in pathophysiology requires multi-dimensional approaches:

Translational Research Framework:

  • Combine findings from animal models with clinical observations

  • Use patient-derived samples to validate mechanisms identified in model systems

Multi-omics Integration:

  • Correlate channel expression/function with transcriptomic profiles

  • Integrate proteomic data to identify interaction partners in disease states

  • Apply metabolomic analysis to assess downstream consequences of channel dysfunction

Disease-Specific Models:

  • For cardiovascular studies: Cardiac-specific genetic manipulations

  • For neurological disorders: Brain region-specific approaches

  • For cancer research: Patient-derived xenografts or organoids

Therapeutic Targeting Validation:

  • Use both genetic and pharmacological modulation

  • Apply rescue experiments to confirm causality

  • Develop biomarkers to track channel activity in vivo

Research has revealed significant links between GIRK channels and various pathological conditions. For example, GIRK1 overexpression in breast cancer is associated with reduced survival times and increased lymph node metastasis . The specific segment comprising amino acids 235-402 appears to be responsible for this cancerogenic action . In addiction research, GIRK channels have been linked to reward circuitry, with genetic evidence demonstrating their sensitivity to alcohol and association with addiction .

How can researchers optimize experimental design when investigating novel modulators of GIRK1 channels?

Designing robust experiments for novel GIRK1 modulators requires careful consideration:

Screening Pipeline Development:

  • Primary screens: Thallium flux assays for higher throughput

  • Secondary validation: Automated patch-clamp electrophysiology

  • Tertiary confirmation: Manual patch-clamp with detailed kinetic analysis

Selectivity Profiling:

  • Test against multiple GIRK subunit combinations

  • Screen against related inward rectifier channels

  • Assess activity on voltage-gated potassium channels

Mechanism of Action Characterization:

  • Direct binding assays (SPR, isothermal titration calorimetry)

  • Competition studies with known modulators

  • Allosteric vs. orthosteric site determination

Structure-Activity Relationship Development:

  • Systematic modification of chemical scaffolds

  • Molecular docking to guide compound optimization

  • Site-directed mutagenesis to validate binding sites

Physiological Relevance Validation:

  • Ex vivo tissue preparations (brain slices, cardiac tissue)

  • In vivo efficacy in disease models

  • PK/PD relationship characterization

When designing such experiments, researchers should consider that GIRK channels can be modulated by multiple factors including G proteins, PIP2, and cholesterol . Comprehensive modulator profiling should account for potential interactions with these endogenous regulatory mechanisms.

What are the most promising approaches for studying GIRK1 structural dynamics during channel gating?

Cutting-edge methodologies for studying GIRK1 structural dynamics include:

Advanced Structural Biology Techniques:

  • Time-resolved cryo-EM to capture transition states

  • Single-particle analysis with various ligands and modulators

  • Hydrogen-deuterium exchange mass spectrometry to identify dynamic regions

Real-time Conformational Monitoring:

  • Voltage-clamp fluorometry with strategically placed fluorophores

  • Single-molecule FRET to detect subunit rearrangements

  • Transition metal ion FRET for precise distance measurements

Computational Approaches:

  • Molecular dynamics simulations of complete channel complexes

  • Markov state modeling of activation pathways

  • Machine learning analysis of conformational ensembles

Novel Spectroscopic Methods:

  • Site-directed spin labeling and electron paramagnetic resonance

  • Vibrational spectroscopy of specific bonds during activation

  • Mass photometry for analysis of complex assembly

While crystallography and cryo-EM studies have significantly advanced the understanding of GIRK-Gβγ interactions, the truncation of the N-terminal domain (NTD) and C-terminal domain (CTD) in these studies remains a significant gap in fully comprehending GIRK channel gating mechanisms . Future structural studies incorporating full-length proteins, including the distal CTD of GIRK1, will be crucial for complete mechanistic understanding.

How can systems biology approaches improve our understanding of GIRK1 in integrated cellular signaling networks?

Systems biology offers powerful frameworks for understanding GIRK1 in cellular context:

Network Analysis:

  • Map GIRK1 interactions within GPCR signaling networks

  • Identify feedback loops involving channel activity and G protein signaling

  • Determine cross-talk with other ion channels and transporters

Quantitative Modeling:

  • Develop mathematical models of GIRK1 channel kinetics

  • Integrate channel activity with cellular excitability models

  • Create multi-scale models linking molecular events to cellular physiology

High-dimensional Data Integration:

  • Single-cell transcriptomics to identify cell-specific GIRK1 regulation

  • Spatial transcriptomics/proteomics to map channel distribution

  • Temporal profiling during physiological state changes

Perturbation Analysis:

  • CRISPR screening to identify novel regulators

  • Pharmacological perturbation with pathway inhibitors

  • Optogenetic control of signaling nodes

Research has shown that GIRK channels are expressed in the brain's reward system and play important roles in various physiological and pathological processes . A systems approach can help contextualize how GIRK1 contributes to these complex neural circuits and behavioral outcomes.

What methodological innovations are needed to better understand the role of GIRK1 splice variants in different physiological contexts?

Advancing our understanding of GIRK1 splice variants requires several methodological innovations:

Improved Detection Systems:

  • Development of splice variant-specific antibodies

  • RNA-based detection methods with single-nucleotide resolution

  • Mass spectrometry protocols optimized for membrane protein variants

Genetic Manipulation Tools:

  • CRISPR-based approaches for variant-specific knockout/knockin

  • Inducible expression systems for temporal control of variant expression

  • Cell type-specific manipulation of splice variant ratios

Functional Characterization Platforms:

  • High-throughput electrophysiology with automated analysis

  • Biosensor development to track variant-specific activity

  • Organoid models to study variants in tissue-specific contexts

Physiological Context Preservation:

  • In vivo splice variant manipulation without disrupting total GIRK1 levels

  • Methods to alter splicing patterns rather than expression levels

  • Approaches to study variant interactions with native signaling machinery

Research has shown that different GIRK1 splice variants (GIRK1a, GIRK1c, GIRK1d) exert differential effects on cellular parameters linked to malignancy . While GIRK1a and GIRK1c reinforce parameters towards malignancy, GIRK1d has the opposite effect . These findings highlight the need for precise tools to study variant-specific functions in various physiological and pathological contexts.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.